이창범 프로필 사진

이창범

Lee, Chang Beom

의과대학

내과학교실

Scopus

연구분야

  • 내분비대사내과

자료 필터

자료유형

발행연도

2000 ~ 2026
2000 2026

키워드

언어

전체 173건 중 1번부터 10번까지의 결과를 표시합니다.

2026
Article

Efficacy and Safety of High-Dose Pioglitazone as Addon Therapy in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Dapagliflozin and Metformin: Double-Blind, Randomized, Placebo-Controlled Trial

  • Hong, Jun Hwa ; 
  • Han, Kyung Ah ; 
  • Hwang, You-Cheol ; 
  • Hong, Eun-Gyoung ; 
  • Kim, Hae Jin ; 
  • ... Lee, Chang Beom ; 
  • 외 7명
  • 2026-03
  • Diabetes and Metabolism Journal
  • KOREAN DIABETES ASSOC
Article

Circulating Branched-Chain Amino Acids are Associated with Higher Odds of Obesity: Findings from the FiLWHEL Study

  • Okekunle, Akinkunmi Paul ; 
  • Lee, Heejin ; 
  • Provido, Sherlyn Mae P. ; 
  • Chung, Grace H. ; 
  • Hong, Sangmo ; 
  • ... Yu, Sung Hoon ; 
  • ... Lee, Chang Beom ; 
  • 외 1명
  • 2026-01
  • NUTRITION AND METABOLIC INSIGHTS
  • SAGE PUBLICATIONS LTD
2025
Article

Efficacy and safety of lobeglitazone added to metformin and sitagliptin combination therapy in patients with type 2 diabetes: A 52-week, multicentre, randomized, placebo-controlled, phase III clinical trial

  • Hong, Eun-Gyoung ; 
  • Min, Kyung-Wan ; 
  • Chun, Sungwan ; 
  • Chung, Choon Hee ; 
  • Oh, Seungjoon ; 
  • ... Lee, Chang Beom ; 
  • 외 13명
  • 2025-10
  • Diabetes, Obesity and Metabolism
  • WILEY
Article

Identifying Factors Associated With Breastfeeding Length Among Filipino Migrant Women in South Korea

  • 2025-04
  • Journal of Human Nutrition and Dietetics
  • WILEY
Article

Evaluation of the efficacy and safety of controlled-release phentermine/topiramate in adults with obesity in Korea: A randomized, double-blind, placebo-controlled, phase 4 trial (QUEEN's study)

  • 2025-03
  • Diabetes, Obesity and Metabolism
  • WILEY
Article

Efficacy and safety of a fixed-dose combination of dapagliflozin and linagliptin (AJU-A51) in patients with type 2 diabetes mellitus: A multicentre, randomized, double-blind, parallel-group, placebo-controlled phase III study

  • 2025-01
  • Diabetes, Obesity and Metabolism
  • WILEY
12345 끝